GeneDx Holdings Corp. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
GeneDx Holdings Corp. (WGS) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent of -27.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-23
- GeneDx Holdings Corp. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2025 was -27.90%.
- GeneDx Holdings Corp. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2024 was -10.70%.
- GeneDx Holdings Corp. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2023 was -18.40%.
- GeneDx Holdings Corp. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2022 was -9.60%.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 6 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 12 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -27.90% 10-K · filed 2026-02-23 | ||
| 2024-12-31 | -10.70% 10-K · filed 2026-02-23 | ||
| 2023-12-31 | -18.40% 10-K · filed 2026-02-23 | ||
| 2022-12-31 | -9.60% 10-K · filed 2024-02-23 | ||
| 2021-12-31 | -32.00% 10-K · filed 2023-03-16 | ||
| 2020-12-31 | -21.00% 10-K · filed 2021-03-30 | -15.90% 10-K · filed 2023-03-16 | 0.00% 10-K/A · filed 2021-05-05 |
| 2019-12-31 | -24.10% 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |